Showing 541-560 of 7110 for: Cochrane Systematic Reviews Back
- Antiepileptic drugs as prophylaxis for post-craniotomy seizures
Cochrane Systematic Reviews, 29-Jun-2015
The incidence of seizures following supratentorial craniotomy for non-traumatic pathology has been estimated to be between 15% to 20%; however, the risk of experiencing a seizure may vary from 3% to 92% over a five-year period. Postoperative seizures can
- Antiepileptic drugs for neuropathic pain and fibromyalgia ‐ an overview of Cochrane reviews
Cochrane Systematic Reviews, 11-Nov-2013
Antiepileptic drugs have been used for treating different types of neuropathic pain, and sometimes fibromyalgia. Our understanding of quality standards in chronic pain trials has improved to include new sources of potential bias. Individual Cochrane revie
- Antiepileptic drugs for preventing seizures following acute traumatic brain injury
Cochrane Systematic Reviews, 16-May-2012
Seizure activity in the early post-traumatic period following head injury may cause secondary brain damage as a result of increased metabolic demands, raised intracranial pressure and excess neurotransmitter release.
- Antiepileptic drugs for preventing seizures in people with brain tumors
Cochrane Systematic Reviews, 19-Oct-2008
Seizures can present at any time before or after diagnosis of a brain tumor. The risk of seizures varies by tumor type and its location in the brain. For a long time we believed that preventing seizures with antiepileptic drugs (seizure prophylaxis) was e
- Antiepileptic drugs for seizure control in people with neurocysticercosis
Cochrane Systematic Reviews, 1-Nov-2021
Neurocysticercosis is the most common parasitic infection of the brain. Epilepsy is the most common clinical presentation, though people may also present with headache, symptoms of raised intracranial pressure, hydrocephalus, and ocular symptoms depending
- Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis
Cochrane Systematic Reviews, 25-Jul-2014
Intracranial venous thrombosis (ICVT) commonly presents with seizures in the acute period, and some people may develop recurrent seizures in the long term. The prophylactic use of antiepileptic drugs (AEDs) for the management of post-ICVT seizures is cont
- Antiepileptic drugs for the primary and secondary prevention of seizures after stroke
Cochrane Systematic Reviews, 21-Jan-2014
This is an updated version of the original Cochrane review published in 2010, Issue 1. Seizures after stroke are an important clinical problem, and they may be associated with poor outcome. The effects of antiepileptic drugs for the primary and secondary
- Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage
Cochrane Systematic Reviews, 29-May-2013
Subarachnoid haemorrhage may result in seizures both acutely and in the longer term. The use of antiepileptic drugs (AEDs) in the primary and secondary prevention of seizures after subarachnoid haemorrhage is uncertain, and there is currently no consensus
- Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis
Cochrane Systematic Reviews, 8-Oct-2014
Viral encephalitis is characterised by diverse clinical and epidemiological features. Seizures are an important clinical manifestation and associated with increased mortality and morbidity. Patients may have seizures during the acute illness or they may d
- Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy
Cochrane Systematic Reviews, 11-Oct-2015
This is an updated version of the original Cochrane review published in Issue 11, 2013.
- Antiepileptic drugs for treating seizures in adults with brain tumours
Cochrane Systematic Reviews, 4-Jul-2011
Seizures are a common symptom of brain tumours. The mainstay of treatment for seizures is medical therapy with antiepileptic drugs.
- Antiepileptics for aggression and associated impulsivity
Cochrane Systematic Reviews, 17-Jan-2010
Aggression is a major public health issue and is integral to several mental health disorders. Antiepileptic drugs may reduce aggression by acting on the central nervous system to reduce neuronal hyper-excitability associated with aggression.
- Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults
Cochrane Systematic Reviews, 14-May-2014
Some antiepileptic drugs but not others are useful in clinical practice for the prophylaxis of migraine. This might be explained by the variety of actions of these drugs in the central nervous system. The present review is part of an update of a Cochrane
- Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children
Cochrane Systematic Reviews, 18-Aug-2015
Scoliosis surgery is often associated with substantial blood loss and potential detrimental effects in children. Antifibrinolytic agents are often used to reduce perioperative blood loss. Clinical trials have evaluated their effect in children undergoing
- Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver disease
Cochrane Systematic Reviews, 8-Jun-2015
Upper gastrointestinal bleeding is one of the most frequent causes of morbidity and mortality in the course of liver cirrhosis. People with liver disease frequently have haemostatic abnormalities such as hyperfibrinolysis. Therefore, antifibrinolytic amin
- Antifibrinolytic drugs for acute traumatic injury
Cochrane Systematic Reviews, 22-May-2015
Uncontrolled bleeding is an important cause of death in trauma victims. Antifibrinolytic treatment has been shown to reduce blood loss following surgery and may also be effective in reducing blood loss following trauma.
- Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
Cochrane Systematic Reviews, 9-Nov-2022
Rebleeding is an important cause of death and disability in people with aneurysmal subarachnoid haemorrhage. Rebleeding is probably related to the dissolution of the blood clot at the site of the aneurysm rupture by natural fibrinolytic activity. This rev
- Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions
Cochrane Systematic Reviews, 19-Apr-2019
Minor oral surgery or dental extractions (oral or dental procedures) are widely performed and can be complicated by hazardous oral bleeding, especially in people with an inherited bleeding disorder such as haemophilia or Von Willebrand disease (VWD). The
- Antifibrinolytic therapy to reduce haemoptysis from any cause
Cochrane Systematic Reviews, 10-Jul-2013
Haemoptysis is a common pathology around the world, occurring with more frequency in low-income countries. It has different etiologies, many of which have infectious characteristics. Antifibrinolytic agents are commonly used to manage bleeding from differ
- Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
Cochrane Systematic Reviews, 15-Feb-2011
Concerns regarding the safety of transfused blood have led to the development of a range of interventions to minimise blood loss during major surgery. Anti-fibrinolytic drugs are widely used, particularly in cardiac surgery, and previous reviews have foun
